News-Medical.Net on MSN3d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Risk for specific hematologic cancers down with GLP-1 receptor agonist use in type 2 diabetes
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications
Weight loss drugs like Ozempic deliver more health benefits than expected. In a study published in the journal Life, ...